New polymorphic form of 1-(4-{L-[(E)-4-cyclohexyl--3-trifluoromethyl-benzyloxyimino]-ethyl)-2-ethyl-benzyl)-azetidine-3-carboxylic

摘要

Hd:arAnIenvven/NRPrtbilDCC/DAR 5352471_ .doc-29/07/2013 This invention relates to a novel crystalline form (Form A) of 1-(4-{l-[(E)-4-cyclohexyl-3 trifluoromethyl-benzyloxyirnino]-ethyl} -2-ethyl-benzyl)-azetid ine-3 -carboxylic acid (Compound I), to pharmaceutical compositions comprising this crystalline form, to processes for forming it and to its use in medical treatment.